New findings on early-stage breast cancer
Traduction du dernier § : Au Etats-Unis, tous les ans, 85 000 femmes dont on a diagnostiqué un cancer de sein du type habituel pourraient se dispenser de subir des séances de chimiothérapie
The majority of women with the most common type of early-stage breast cancer can safely skip chemotherapy after surgery, according to a highly anticipated new report.
The findings, from the largest breast cancer treatment trial ever conducted, showed that most patients who have an intermediate risk of a cancer recurrence — a group that numbers 65,000 women a year in the United States — can avoid chemotherapy and its often debilitating side effects.
The same decade-long study had previously confirmed that patients at low risk, as determined by a genomic test of their tumors, can skip chemotherapy.
The two groups taken together account for about 70 percent of women diagnosed with the most common type of breast cancer. That means more than 85,000 women a year can safely forgo chemotherapy.